The AMR Equation: Where innovation meets urgency

As drug-resistant infections undermine modern medicine and deepen global health inequities, this event explores how health diplomacy and cross-sector collaboration can accelerate action on AMR.

Discussions will spotlight the intersection of AMR with cancer care, maternal health, and chronic disease management, while addressing urgent needs in access, stewardship, and global R&D alignment.

Join distinguished stakeholders from the public sector, private sector, not-for-profit organisations, intergovernmental organisations and AMR survivors, as we foster a dialogue on One Health-driven best practices to address the burden of AMR.

Key Themes:

• Health Diplomacy in AMR: Bridging Geopolitical Divides for Equitable Action.
• Science: Rapid diagnostics, novel therapies, and the Independent Panel on Evidence for Action against Antimicrobial Resistance.
• Collaborative governance: Public-Private Partnerships and the One Health Approach.
• Policy Integration: Linking AMR efforts to emergency preparedness, NCD control, and climate resilience.
• Funding Mechanisms: Promoting R&D and ensuring access in low-resource settings.

Speakers:

• Dr. Dame Sally Davies, UK Special Envoy on Antimicrobial Resistance, United Kingdom
• Dr. Ntuli Angyelile Kapologwe, Director General, The East, Central and Southern Africa Health Community
• Ms. Eva Rennen, Vice-President NosticsVice President of the Board, BEAM Alliance
• Sadhavi Chauhan, Government Engagement and Policy Manager, Access to Medicine Foundation
• Per Wahlstedt, Expert in Healthcare, Swedish Cancer Society
• Vanessa Carter, Chair of the WHO Task Force of AMR Survivors and Executive Director of The AMR Narrative